Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode

被引:1
|
作者
Yanagisawa, Atsushi
Takimoto, Takayuki
Shintani, Ryota
Kobayashi, Takehiko
Hirose, Masaki
Arai, Toru [1 ]
Inoue, Yoshikazu
机构
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Japan
关键词
pulmonary alveolar proteinosis; coronavirus disease 2019 (COVID-19); viral infection; granulocyte -macrophage colony-stimulating factor (GM-CSF); GM-CSF; DISEASE; REMISSION;
D O I
10.2169/internalmedicine.1592-23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction owing to the presence of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies. A 77-year-old man with APAP was referred to our hospital for whole-lung lavage (WLL) due to oxygenation exacerbation and pulmonary shadows. The patient had had coronavirus disease 2019 (COVID-19) during the APAP evaluation before WLL. About three months after COVID-19 resolved, his oxygenation and shadow reflecting APAP had obviously improved, thus avoiding the need for WLL. We suspected that the improvement in APAP was due to various immunological reactions induced by COVID-19.
引用
收藏
页码:2237 / 2241
页数:5
相关论文
共 50 条
  • [21] Pulmonary alveolar proteinosis: a new autoimmune disease
    Costabel, U
    Guzman, J
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2005, 22 : S67 - S73
  • [22] Rituximab therapy in autoimmune pulmonary alveolar proteinosis
    Borie, R.
    Debray, M-P.
    Laine, C.
    Aubier, M.
    Crestani, B.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) : 1503 - 1506
  • [23] Autoimmune Pulmonary Alveolar Proteinosis: Two Cases
    Modi, P.
    Baqir, M.
    Kalra, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [24] Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis
    Juarez-Molina, Claudia I.
    Lund-Palau, Helena
    Meng, Cuixiang
    Gill, Deborah
    Hyde, Stephen
    Alton, Eric
    Griesenbach, Uta
    MOLECULAR THERAPY, 2021, 29 (04) : 256 - 257
  • [25] Immune dysfunction in autoimmune pulmonary alveolar Proteinosis
    Uchida, K.
    Beck, D. C.
    Yamamoto, T.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (05) : 319 - 320
  • [26] Elemental Analysis Of Autoimmune Pulmonary Alveolar ProteINOSis
    Moriyama, H.
    Kobayashi, M.
    Aoki, A.
    Asakawa, K.
    Sakagami, T.
    Koya, T.
    Kagamu, H.
    Takada, T.
    Narita, I.
    Inoue, Y.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [27] A RARE CASE OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS
    Kim, Joseph
    Silverstein, Nicole
    CHEST, 2023, 164 (04) : 3356A - 3357A
  • [28] Longitudinal Cohort Of Autoimmune Pulmonary Alveolar ProteINOSis
    Inoue, Y.
    Arai, T.
    Nakata, K.
    Yamaguchi, E.
    Ichiwata, T.
    Ebina, M.
    Tazawa, R.
    Ishii, H.
    Setoguchi, Y.
    Kitaichi, M.
    Akira, M.
    Tatsumi, K.
    Nasuhara, Y.
    Cho, K.
    Tsuchihashi, Y.
    Uchida, K.
    Takada, T.
    Nakayama, H.
    Tomii, K.
    Sugimoto, C.
    Kohashi, Y.
    Ohkouchi, S.
    Kasahara, Y.
    Morimoto, K.
    Nakatani, T.
    Tsuyuguchi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [29] Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
    Tanaka, Yuko
    Shirai, Toshihiro
    Asada, Kazuhiro
    Muramatsu, Aya
    Katsumata, Mineo
    Suda, Takafumi
    CLINICAL CASE REPORTS, 2019, 7 (04): : 731 - 734
  • [30] Alveolar Proteinosis Following COVID-19 Infection: Cause or Confounder?
    Middendorf, M.
    Sukkar, A.
    Libre, E.
    Mani, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207